AB040. Early and long-term protective effect of uncultured adipose stromal vascular fraction against renal ischemia-reperfusion injury via pre-ischemic administration
Laboratory Study on Chronic Kidney Disease, Acute Kidney Injury, Chronic Wound, published in Transl Androl Urol (2016) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Transl Androl Urol (2016)
- Reported sample size
- —
- Source database
- Europe PMC
- PMCID
- PMC4842654
Abstract (original English)
Background Ischemia-reperfusion (IR) induced acute kidney injury (AKI) is the common clinical syndrome. Stem/progenitor cells therapy is a promising option to foster the intrinsic capacity of renal regeneration. However, several challenges still remain due to the potential risks during in vitro cell culture, low retention rate after transplantation and unclear effect on the progression of chronic kidney disease (CKD). Adipose stromal vascular fraction (SVF) is regarded as an attractive cell source for cell-based therapy without need of in vitro expansion. Preconditioning with ischemia has been suggested to be a useful method to induce a delay of lethal cell injury, enhance cellular tolerance to injurious effects of IR, and promote cell retention and survival. The purpose of this study is to investigate the effect of pre-administration of uncultured adipose SVF on IR induced AKI and progression of fibrosis. Methods SVF was isolated from rat epididymal adipose tissue and characterized by flow cytometric analysis. Cell proliferation and scrape wound healing assay was performed by a co-culture system to evaluate the effects of SVF pre-hypoxic administration on proliferation, migration and apoptosis of renal tubular epithelial cells in hypoxic environment. IR induced kidney injury model was established and CM-DiI labeled SVF was injected to the subcapsular pre- or post-ischemia. Ren
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review
Systematic Review on Chronic Kidney Disease, published in Ren Fail (2026) — summary generated from the PubMed abstract.
- 2026
Ren Fail - Level AMeta-analysisEurope PMC
Meta-analysis study of the therapeutic impact of Mesenchymal stem cells derived exosomes for chronic kidney diseases
Meta-analysis on Chronic Kidney Disease, published in Biochem Biophys Rep (2025) — summary generated from the PubMed abstract.
- 2025
Biochem Biophys Rep2 citations - Level ASystematic ReviewPubMed
Clinical Safety and Efficacy of Allogeneic Adipose Stem Cells: A Systematic Review of the Clinical Trials.
Systematic Review with a reported sample of 953 on Osteoarthritis, Chronic Kidney Disease, Scar, Autoimmune Research, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
- n = 953
Int J Mol Sci2 citations - Level ASystematic ReviewEurope PMC
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024
Systematic Review on Chronic Kidney Disease, Acute Kidney Injury, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol2 citations - Level AMeta-analysisEurope PMC
Mesenchymal Stem Cells as Anti-Inflammatory Agents in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Meta-analysis on Chronic Kidney Disease, Chronic Inflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level AMeta-analysisEurope PMC
Protective role of exosomes in renal ischemia-reperfusion injury: a systematic review and meta-analysis
Meta-analysis on Chronic Kidney Disease, Acute Kidney Injury, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol1 citations